Search

Your search keyword '"Epoxyeicosatrienoic acid"' showing total 924 results

Search Constraints

Start Over You searched for: Descriptor "Epoxyeicosatrienoic acid" Remove constraint Descriptor: "Epoxyeicosatrienoic acid"
924 results on '"Epoxyeicosatrienoic acid"'

Search Results

1. Triazine herbicide prometryn alters epoxide hydrolase activity and increases cytochrome P450 metabolites in murine livers via lipidomic profiling

2. The epoxy fatty acid pathway enhances cAMP in mammalian cells through multiple mechanisms

3. Genetic variants in epoxyeicosatrienoic acid processing and degradation pathways are associated with gestational diabetes mellitus

4. Genetic variants in epoxyeicosatrienoic acid processing and degradation pathways are associated with gestational diabetes mellitus.

5. Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases

6. Eicosanoids in human heart failure: pilot study of plasma epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels

7. Eicosanoids in human heart failure: pilot study of plasma epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels.

8. Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats

9. Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy.

10. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption

11. Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease

12. Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension

13. Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunction.

14. Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fraction

15. N-Methyl-D-Aspartic Acid Receptor-Mediated Vasodilation Is Attenuated in the Retinas of Diabetic Rats.

16. Repurposing of digoxin in pain and inflammation: An evidence‐based study.

17. Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2.

18. Epoxyeicosatrienoic Acid and Prostanoid Crosstalk at the Receptor and Intracellular Signaling Levels to Maintain Vascular Tone.

19. Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling

20. Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.

21. Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen‐glucose deprivation

22. Probing the orientation of inhibitor and epoxy-eicosatrienoic acid binding in the active site of soluble epoxide hydrolase

23. SMTP-44D Exerts Antioxidant and Anti-Inflammatory Effects through Its Soluble Epoxide Hydrolase Inhibitory Action in Immortalized Mouse Schwann Cells upon High Glucose Treatment.

24. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress

25. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model

26. ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways

27. Role of endothelium-pericyte signaling in capillary blood flow response to neuronal activity.

28. Effects and mechanism of arachidonic acid against TNF-α induced apoptosis of endothelial cells.

29. Epoxyeicosatrienoic acids and cardioprotection: The road to translation

30. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure

31. Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer

32. Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome

33. Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice

34. Soluble Epoxide Hydrolase in Atherosclerosis

35. Cytochrome P450 epoxygenase‐derived 5,6‐epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia.

36. ZDHXB-101 (3',5-Diallyl-2, 4'-dihydroxy-[1,1'-biphen-yl]-3,5'-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways.

37. CYP2J2/EET reduces vulnerability to atrial fibrillation in chronic pressure overload mice.

38. Effects of Dynamic Exercise on Plasma Arachidonic Acid Epoxides and Diols in Human Volunteers.

39. Association between the soluble epoxide hydrolase gene and preeclampsia

40. CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina

41. EICOSANOIDS AND INFLAMMATION

42. New Lipid Mediators in Retinal Angiogenesis and Retinopathy

43. Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats

44. Inhibition of Soluble Epoxide Hydrolase for Renal Health

45. Cytokine and inflammatory mediator effects on TRPV4 function in choroid plexus epithelial cells.

46. Epoxyeicosanoids in Hypertension.

47. New Lipid Mediators in Retinal Angiogenesis and Retinopathy.

48. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure.

49. Epoxyeicosatrienoic acid Metabolism in Preeclampsia.

Catalog

Books, media, physical & digital resources